Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Clinical trial NCT03138733 · COMPLETED
Trial details
- NCT number
- NCT03138733
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-26
- Primary completion
- 2022-03-11
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.